Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Measuring the quality of life of people with severe leprosy and lymphatic filariasis disability in India using an informal, intervention-focused, contextual, and integrated tool for NTD disability

Anand S, Kant Singh R, John A, et al. Lepra. Leprosy Review. 2024; 95 (3) : 1-15.
Download PDF
Publication

Robust contact tracing and screening needed for leprosy control and protection of vulnerable children

Pilaka K, Pallapati M, Jaladi Z, et al. The Iranian Journal of Microbiology . 2024;
Download PDF
Publication

Cystic Subcutaneous Phaeohyphomycosis Caused by Cladophialophora Species in an Elderly Leprosy Patient

Kumar PBP, Mala M, Jacob ES. Springer Science and Business Media LLC. Cureus. 2024;
Download PDF
Publication

Erythema nodosum leprosum: condition developed by non-adherence

Gladwin E, Patel M, Mistry M. Innovare Academic Sciences Pvt Ltd. International Journal of Pharmacy and Pharmaceutical Sciences. 2024;
Download PDF
Publication

Clinically Suspicious Cases of Hansen's Disease at a Tertiary Care Hospital in South India: A Clinicopathological Study

Shabnam A, Dennis Joseph L, Priyathersini N, et al. Springer Science and Business Media LLC. Cureus. 2024;
Download PDF
Publication

Unveiling the nerve bumps in Hansen’s arm and forearm

Sugumar R, Gomathy B, Cannane S. Scientific Scholar. Case Reports in Clinical Radiology. 2024;
Download PDF
Publication

Clinically Suspicious Cases of Hansen's Disease at a Tertiary Care Hospital in South India: A Clinicopathological Study

Shabnam A, Dennis Joseph L, Priyathersini N, et al. Springer Science and Business Media LLC. Cureus. 2024;
Download PDF
Publication

Demography of Leprosy Patients Presenting with Altered Skin Pigmentation in the State Capital of North India

Prakash S, Saquib M, Sharma B, et al. International Journal of Scientific Research. 2024;
Download PDF
Publication

Black Dots and Broken Hairs in Leprosy Unveiled by Dermoscopy

Verghese H, Sudhakar Rao K. Indian Journal of Leprosy. 2024;
Download PDF
Publication

An Unusual Cutaneous Manifestation of Tuberculoid Spectrum in Leprosy

Satish S, Fernandes S, Bhat RM, et al. Indian Journal of Leprosy. 2024;
Download PDF

Pagination

  • Previous page ‹‹
  • Page 7
  • Next page ››
Subscribe to India

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • Contact
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

  • infontd

© 2025 InfoNTD